These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8542945

  • 1. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
    Hanenberg H, Dilloo D, Laws HJ, Zessack N, Heyll A, Burdach S.
    Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945
    [Abstract] [Full Text] [Related]

  • 2. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 3. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
    Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Leblanc P, Symann ML.
    Cancer Res; 1994 Jul 15; 54(14):3800-7. PubMed ID: 7913409
    [Abstract] [Full Text] [Related]

  • 4. Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia.
    Hsu HC, Tsai WH, Chen LY, Hsu ML, Ing-Tiau Kuo B, Ho CH, Lin CK, Wang SY.
    Exp Hematol; 1996 Jan 15; 24(1):31-6. PubMed ID: 8536789
    [Abstract] [Full Text] [Related]

  • 5. G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function.
    Nawa Y, Teshima T, Sunami K, Hiramatsu Y, Maeda Y, Yano T, Shinagawa K, Ishimaru F, Omoto E, Harada M.
    Bone Marrow Transplant; 2000 May 15; 25(10):1035-40. PubMed ID: 10828862
    [Abstract] [Full Text] [Related]

  • 6. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
    Baiocchi G, Scambia G, Benedetti P, Menichella G, Testa U, Pierelli L, Martucci R, Foddai ML, Bizzi B, Mancuso S.
    Cancer Res; 1993 Mar 15; 53(6):1297-303. PubMed ID: 7680283
    [Abstract] [Full Text] [Related]

  • 7. Cytokine production in long-term marrow cultures after autologous bone marrow transplantation.
    Roingeard F, Domenech J, Dayan A, Gihana E, Colombat P, Binet C.
    Bone Marrow Transplant; 1995 May 15; 15(5):741-7. PubMed ID: 7545488
    [Abstract] [Full Text] [Related]

  • 8. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S, Saï P, Bach JM.
    Immunol Lett; 2004 Feb 15; 91(2-3):221-7. PubMed ID: 15019293
    [Abstract] [Full Text] [Related]

  • 9. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M, Kanamori H, Takasaki H, Yamaji S, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujisawa S, Maruta A, Ishigatsubo Y.
    Exp Hematol; 2005 Feb 15; 33(2):251-7. PubMed ID: 15676220
    [Abstract] [Full Text] [Related]

  • 10. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A, Barak V, Novick D, Nagler A.
    Cytokines Cell Mol Ther; 1997 Sep 15; 3(3):153-8. PubMed ID: 9426973
    [Abstract] [Full Text] [Related]

  • 11. Peripheral blood mononuclear cells from autologous hematopoietic stem cell transplantation recipients produce and respond to IL-12.
    Guillaume T, Kubin M, Sekhavat M, Rubinstein DB, Trinchieri G, Symann M.
    Bone Marrow Transplant; 1996 Oct 15; 18(4):733-9. PubMed ID: 8899188
    [Abstract] [Full Text] [Related]

  • 12. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 15; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS, Barsig J, Hartung T, Randow F, Döcke WD, Volk HD, Wendel A.
    J Immunol; 1997 Mar 15; 158(6):2862-71. PubMed ID: 9058823
    [Abstract] [Full Text] [Related]

  • 14. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
    Chong AS, Scuderi P, Grimes WJ, Hersh EM.
    J Immunol; 1989 Mar 15; 142(6):2133-9. PubMed ID: 2493506
    [Abstract] [Full Text] [Related]

  • 15. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.
    Yabe M, Yabe H, Hattori K, Shimizu T, Matsumoto M, Morimoto T, Yasuda Y, Inoue H, Kato S, Nishimura T.
    Bone Marrow Transplant; 1999 Jul 15; 24(1):29-34. PubMed ID: 10435731
    [Abstract] [Full Text] [Related]

  • 16. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D, Kunst D, Hempel L, Söhngen D, Heyll A, Bönig H, Göbel U, Zintl F, Burdach S.
    Bone Marrow Transplant; 1997 Apr 15; 19(7):691-5. PubMed ID: 9156246
    [Abstract] [Full Text] [Related]

  • 17. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
    Wu JM, Bensen-Kennedy D, Miura Y, Thoburn CJ, Armstrong D, Vogelsang GB, Hess AD.
    Biol Blood Marrow Transplant; 2005 Jun 15; 11(6):455-64. PubMed ID: 15931634
    [Abstract] [Full Text] [Related]

  • 18. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P.
    Biol Blood Marrow Transplant; 1997 Oct 15; 3(4):217-23. PubMed ID: 9360784
    [Abstract] [Full Text] [Related]

  • 19. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Oct 15; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 20. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M, Hashino S, Kobayashi H, Kubayashi S, Hirano S, Minagawa T, Tanaka J, Fujii Y, Kobayashi M, Kasai M.
    Bone Marrow Transplant; 1994 Jun 15; 13(6):745-51. PubMed ID: 7920309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.